Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Inhibition of telomerase induces alternative lengthening of telomeres during human esophageal carcinogenesis.

Queisser A, Heeg S, Thaler M, von Werder A, Opitz OG.

Cancer Genet. 2013 Nov;206(11):374-86. doi: 10.1016/j.cancergen.2013.10.001. Epub 2013 Oct 11.

PMID:
24331919
2.

EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis.

Heeg S, Hirt N, Queisser A, Schmieg H, Thaler M, Kunert H, Quante M, Goessel G, von Werder A, Harder J, Beijersbergen R, Blum HE, Nakagawa H, Opitz OG.

Cancer Sci. 2011 Feb;102(2):351-60. doi: 10.1111/j.1349-7006.2010.01796.x. Epub 2010 Dec 12.

3.

Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.

Quante M, Heeg S, von Werder A, Goessel G, Fulda C, Doebele M, Nakagawa H, Beijersbergen R, Blum HE, Opitz OG.

Carcinogenesis. 2005 Nov;26(11):1879-89. Epub 2005 Jun 15.

PMID:
15958520
4.

Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer.

Heeg S.

Pharmgenomics Pers Med. 2015 Dec 4;8:171-80. doi: 10.2147/PGPM.S52808. eCollection 2015. Review.

5.

Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.

Gocha AR, Harris J, Groden J.

Mutat Res. 2013 Mar-Apr;743-744:142-50. doi: 10.1016/j.mrfmmm.2012.11.006. Epub 2012 Dec 3. Review.

6.

Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.

Sun B, Chen M, Hawks CL, Hornsby PJ.

Cancer Res. 2005 Aug 1;65(15):6512-5.

7.

Telomere lengthening in telomerase-negative cells: the ends are coming together.

Scheel C, Poremba C.

Virchows Arch. 2002 Jun;440(6):573-82. Epub 2002 Apr 9. Review.

PMID:
12070595
8.

Telomere length maintenance in aging and carcinogenesis.

Aragona M, Maisano R, Panetta S, Giudice A, Morelli M, La Torre I, La Torre F.

Int J Oncol. 2000 Nov;17(5):981-9. Review.

PMID:
11029502
9.

Alternative lengthening of telomeres in human cells.

Reddel RR, Bryan TM, Colgin LM, Perrem KT, Yeager TR.

Radiat Res. 2001 Jan;155(1 Pt 2):194-200. Review.

PMID:
11121234
10.

Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.

Brachner A, Sasgary S, Pirker C, Rodgarkia C, Mikula M, Mikulits W, Bergmeister H, Setinek U, Wieser M, Chin SF, Caldas C, Micksche M, Cerni C, Berger W.

Cancer Res. 2006 Apr 1;66(7):3584-92.

12.

Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?

Nittis T, Guittat L, Stewart SA.

Biochimie. 2008 Jan;90(1):5-12. Epub 2007 Sep 2. Review.

PMID:
17935854
13.

Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells.

Zuo J, Wang DH, Zhang YJ, Liu L, Liu FL, Liu W.

Oncol Rep. 2013 Oct;30(4):1823-31. doi: 10.3892/or.2013.2649. Epub 2013 Aug 1.

PMID:
23912465
14.

Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.

Grobelny JV, Kulp-McEliece M, Broccoli D.

Hum Mol Genet. 2001 Sep 1;10(18):1953-61.

PMID:
11555632
15.

Alternative lengthening of telomeres is induced by telomerase inhibitors in Barrett's esophageal cells.

Qin X, Qi B, Zhao B.

Oncol Rep. 2013 Apr;29(4):1399-404. doi: 10.3892/or.2013.2238. Epub 2013 Jan 17.

PMID:
23338150
16.

Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.

Perrem K, Bryan TM, Englezou A, Hackl T, Moy EL, Reddel RR.

Oncogene. 1999 Jun 3;18(22):3383-90.

17.

Telomere maintenance and tumorigenesis: an "ALT"ernative road.

Stewart SA.

Curr Mol Med. 2005 Mar;5(2):253-7. Review.

PMID:
15974880
18.

Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells.

Burger AM, Fiebig HH, Kuettel MR, Lautenberger JA, Kung HF, Rhim JS.

Int J Oncol. 1998 Nov;13(5):1043-8.

PMID:
9772298
19.

Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.

Zhuang ZH, Tsao SW, Deng W, Wang JD, Xia HH, He H, Feng HC, Wang LD, Gu Q, Lam SK, Lin MC, Kung HF, Wong BC.

J Gastroenterol Hepatol. 2008 Oct;23(10):1613-20. doi: 10.1111/j.1440-1746.2008.05509.x. Epub 2008 Aug 20.

PMID:
18717758
20.

A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.

Cerone MA, Autexier C, LondoƱo-Vallejo JA, Bacchetti S.

Oncogene. 2005 Nov 24;24(53):7893-901.

PMID:
16116482

Supplemental Content

Support Center